Comparing Rexulti vs Viibryd
| Rexulti (brexpiprazole) | Viibryd (vilazodone) |
|
|---|
| Rexulti (brexpiprazole) | Viibryd (vilazodone) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Rexulti is an atypical antipsychotic that may be used to treat adults with schizophrenia or depression, or used to relieve agitation associated with dementia in Alzheimer's disease. Most people... View more |
Prescription only
Prescribed for Major Depressive Disorder, Depression. Viibryd may also be used for purposes not listed in this medication guide. |
Related suggestions Depression
Major Depressive Disorder
|
|||||||
| More about Rexulti (brexpiprazole) | More about Viibryd (vilazodone) | ||||||||
| Ratings & Reviews | |||||||||
|
Rexulti has an average rating of 6.6 out of 10 from a total of 490 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 26% reported a negative effect. |
Viibryd has an average rating of 5.9 out of 10 from a total of 858 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 34% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Rexulti side effects |
View all Viibryd side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Rexulti prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
|
N/A |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
91 hours |
25 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 600 drugs are known to interact with Rexulti:
|
A total of 436 drugs are known to interact with Viibryd:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
July 10, 2015 |
January 21, 2011 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.